Physician profile
Silvio Podda
NPI 1366564460
$1,515.72
in general payments reported to CMS, 2019-2025
12 companies · $560 in 2025
The $560 reported for 2025 was more than what 80% of Pediatric Surgery providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $49.57 · 2021: $52.45 · 2022: $102 · 2023: $274 · 2024: $195 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $355.46 | 2025 | |
| Integra Lifesciences Corporation | $345.63 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $224.22 | 2023-2025 | |
| Medtronic, INC. | $124.92 | 2023 | Corevalve Evolut R |
| Derma Sciences, INC. | $121.85 | 2019 | |
| Cranial Technologies, INC | $116.38 | 2019-2025 | Doc Band |
| Kls-Martin L.P. | $73.28 | 2020-2025 | |
| Davol INC. | $50.18 | 2025 | Channel Drain |
| Smith+Nephew, INC. | $37.08 | 2019-2020 | |
| Allergan, INC. | $26.33 | 2021 | |
| Solventum Corporation | $23.43 | 2025 | V.A.C.Ulta, Prevena |
| Vertex Pharmaceuticals Incorporated | $16.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silvio Podda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.